| Browse All

PMGC Holdings Inc. (ELAB)

Healthcare | Biotechnology | Newport Beach, United States | NasdaqCM
3.29 USD -0.03 (-0.904%) ⇩ (April 21, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | April 19, 2026, midnight EDT

Extreme dilution and fundamental collapse render ELAB uninvestable; the massive stock offering driving current volatility is a cash grab for a company with gross margins of -174%, negative free cash flow, and a forecasting model predicting a -14% price move over the next 45 days.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.262090
AutoARIMA0.589664
AutoETS0.711530
MSTL0.893896

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 18%
H-stat 7.59
Ljung-Box p 0.001
Jarque-Bera p 0.000
Excess Kurtosis 3.91
Attribute Value
Sector Healthcare
Debt to Equity Ratio 33.748
Revenue per Share 28.994
Market Cap 14,642,299
Beta 0.71
Previous Name Elevai Labs, Inc.
Website https://pmgcholdings.com

Info Dump

Attribute Value
52 Week Change -0.9865743
Address1 120 Newport Center Drive
Address2 Suite 249
All Time High 500,345.25
All Time Low 1.62
Ask 4.07
Ask Size 2
Average Daily Volume10 Day 14,420,630
Average Daily Volume3 Month 7,469,177
Average Volume 7,469,177
Average Volume10Days 14,420,630
Beta 0.706
Bid 2.39
Bid Size 2
Book Value 97.111
City Newport Beach
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.29
Current Ratio 1.743
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 3.3487
Day Low 3.1501
Debt To Equity 33.748
Display Name PMGC
Ebitda -7,026,714
Ebitda Margins 0.0
Enterprise To Ebitda -0.055
Enterprise To Revenue 0.655
Enterprise Value 386,752
Eps Trailing Twelve Months -382.61
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 5.52718
Fifty Day Average Change -2.2371802
Fifty Day Average Change Percent -0.40475976
Fifty Two Week Change Percent -98.65743
Fifty Two Week High 309.89474
Fifty Two Week High Change -306.60474
Fifty Two Week High Change Percent -0.98938346
Fifty Two Week Low 1.62
Fifty Two Week Low Change 1.67
Fifty Two Week Low Change Percent 1.0308641
Fifty Two Week Range 1.62 - 309.89474
Financial Currency USD
First Trade Date Milliseconds 1,700,577,000,000
Float Shares 1,157,420
Free Cashflow -2,762,601
Full Exchange Name NasdaqCM
Full Time Employees 32
Gmt Off Set Milliseconds -14,400,000
Gross Margins -1.74948
Gross Profits -1,032,340
Has Pre Post Market Data 1
Held Percent Insiders 0.00064000004
Held Percent Institutions 0.00054000004
Implied Shares Outstanding 4,450,547
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,023-11-21
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,773,100,800
Last Split Factor 1:6
Long Business Summary PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Long Name PMGC Holdings Inc.
Market us_market
Market Cap 14,642,299
Market State PRE
Max Age 86,400
Message Board Id finmb_1683617420
Most Recent Quarter 1,767,139,200
Name Change Date 2,026-04-20
Net Income To Common -7,780,740
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 14,642,299
Open 3.3
Operating Cashflow -5,933,881
Operating Margins -9.44994
Payout Ratio 0.0
Phone 866 445 4886
Pre Market Change 0.0
Pre Market Change Percent 0.0
Pre Market Price 3.29
Pre Market Time 1,776,847,880
Prev Name Elevai Labs, Inc.
Previous Close 3.32
Price Hint 4
Price To Book 0.03387876
Price To Sales Trailing12 Months 24.813923
Profit Margins 0.0
Quick Ratio 1.627
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.03
Regular Market Change Percent -0.903614
Regular Market Day High 3.3487
Regular Market Day Low 3.1501
Regular Market Day Range 3.1501 - 3.3487
Regular Market Open 3.3
Regular Market Previous Close 3.32
Regular Market Price 3.29
Regular Market Time 1,776,801,601
Regular Market Volume 1,363,982
Return On Assets -0.4073
Return On Equity -1.0734301
Revenue Per Share 28.994
Sand P52 Week Change 0.3140242
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 4,450,547
Shares Percent Shares Out 1.4164
Shares Short 1,641,785
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 14,458
Short Name PMGC Holdings Inc.
Short Percent Of Float 1.4165
Short Ratio 0.17
Source Interval 15
State CA
Symbol ELAB
Total Cash 6,072,312
Total Cash Per Share 5.239
Total Debt 2,644,949
Total Revenue 590,084
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -382.61
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 90.75929
Two Hundred Day Average Change -87.46929
Two Hundred Day Average Change Percent -0.96375024
Type Disp Equity
Volume 1,363,982
Website https://pmgcholdings.com
Zip 92,660